ISpecimen Company Insiders

ISPC Stock  USD 1.08  0.05  4.85%   
ISpecimen employs about 24 people. The company is managed by 15 executives with a total tenure of roughly 56 years, averaging almost 3.0 years of service per executive, having 1.6 employees per reported executive. Evaluation of ISpecimen's management performance can provide insight into the firm performance.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iSpecimen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade ISpecimen Stock refer to our How to Trade ISpecimen Stock guide.

ISpecimen Management Team Effectiveness

The company has return on total asset (ROA) of (0.734) % which means that it has lost $0.734 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6537) %, meaning that it created substantial loss on money invested by shareholders. ISpecimen's management efficiency ratios could be used to measure how well ISpecimen manages its routine affairs as well as how well it operates its assets and liabilities.

ISpecimen Workforce Comparison

iSpecimen is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 649. ISpecimen holds roughly 24.0 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.4) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.55) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.55.

ISpecimen Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ISpecimen insiders, such as employees or executives, is commonly permitted as long as it does not rely on ISpecimen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ISpecimen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ISpecimen Notable Stakeholders

An ISpecimen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ISpecimen often face trade-offs trying to please all of them. ISpecimen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ISpecimen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert LimTreasurer, CEOProfile
Katharyn FieldPresidentProfile
Emily HubbardVP DevelProfile
Benjamin BielakChief SecretaryProfile
Eric LangloisChief OfficerProfile
Dawn MichelleVP OperationsProfile
Yuying LiangChief OfficerProfile
Annette ArnoldVice DevelopmentProfile
Tracy CurleyTreasurer CFOProfile
Brielan SmiechowskiSenior DevelopmentProfile
Carly LejnieksVice MarketingProfile
Leslie HoytSenior OperationsProfile
Jill MullanS DirectorProfile
David MDChief OfficerProfile
Evan CoxSenior InnovationProfile

About ISpecimen Management Performance

The success or failure of an entity such as iSpecimen often depends on how effective the management is. ISpecimen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ISpecimen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ISpecimen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts. Ispecimen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Please note, the presentation of ISpecimen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ISpecimen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ISpecimen's management manipulating its earnings.

ISpecimen Workforce Analysis

Traditionally, organizations such as ISpecimen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ISpecimen within its industry.

ISpecimen Manpower Efficiency

Return on ISpecimen Manpower

Revenue Per Employee387.1K
Revenue Per Executive619.4K
Net Loss Per Employee520.7K
Net Loss Per Executive833.2K

Complementary Tools for ISpecimen Stock analysis

When running ISpecimen's price analysis, check to measure ISpecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISpecimen is operating at the current time. Most of ISpecimen's value examination focuses on studying past and present price action to predict the probability of ISpecimen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISpecimen's price. Additionally, you may evaluate how the addition of ISpecimen to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules